On February 22,2013, the US Food and Drug Administration (FDA) approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists.
...
Alert Date
On February 22,2013, the US Food and Drug Administration (FDA) approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists.
...